Equillium, Inc. Common Stock (EQ) is a publicly traded Healthcare sector company. As of July 13, 2026, EQ trades at $3.03 with a market cap of $183.99M and a P/E ratio of -7.44. EQ moved +3.95% today. Year to date, EQ is +87.74%; over the trailing twelve months it is +735.73%. Its 52-week range spans $0.27 to $3.54. Analyst consensus is strong buy with an average price target of $7.17. Rallies surfaces EQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EQ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EQ recently traded at $3.03. Market cap is $183.99M. P/E ratio is -7.44. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $3.03 |
| Market Cap | $183.99M |
| P/E Ratio | -7.44 |
| EPS | $-0.39 |
| Dividend Yield | 0.69% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.27 |
| Volume | 7.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.40M |
| Gross Margin | 0.00% |
6 analysts cover EQ: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.17.